BTIG to Host Ophthalmology Day at BTIG on November 30, 2021

New York – November 11, 2021 – BTIG announced today that Ophthalmology Day at BTIG will take place on Tuesday, November 30, 2021. The virtual, one-day event will include thematic panel discussions, fireside chats and one-on-one meetings. The event will be hosted by Ryan Zimmerman, BTIG Medical Technology Analyst, as well as Tom Shrader, PhD, CFA, and Yun Zhong, PhD, BTIG Biotechnology Analysts.

“Early-stage private and public medical technology and therapeutics companies are taking on some of the largest challenges facing ophthalmic disease today,” commented Mr. Zimmerman. “Our event will provide a forum for BTIG’s institutional investor clients to explore emerging innovation in ophthalmology and take a look at what’s on the horizon.”

More than 25 public and private medical technology and biotechnology companies will be participating in BTIG’s event this month. Panel discussion topics will include exploring the latest developments and trends within ophthalmic medical technologies and therapeutics.

For more information about the event, email [email protected]. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a firm representative or log in to www.btigresearch.com.

Ophthalmology Day at BTIG is being produced by BTIG’s Corporate Access program which hosts client events across the consumer, energy and infrastructure, financials, healthcare, real estate as well as technology, media, and telecommunications sectors.

###

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 19 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. Disclaimer: https://www.btig.com/disclaimer.

To learn more about BTIG, visit www.btig.com.

Media Contacts:

Jill Gordon
443.668.2055
[email protected]

Amanda Gold
212.738.6134
[email protected]